Sales manager:Emily
whatsapp：+852 9720 1305
Email:emily@xtmingheng.com

sincerely look forward to your inquiries about our products.

• IGF DES stems from Insulin Like Growth Factor 1 or IGF 1 for short. This new variation of the peptide is a shortened analogue of the full IGF 1 peptide. The main difference comes in the form of the first three amino acids. In the case of the shortened peptide, the three amino acids are taken out at the N-terminus. The N-terminus more simply refers to the beginning of a protein or polypeptide. This means that instead of the 70 amino acids commonly related to IGF 1, this newly shortened strain called IGF DES only has 67 amino acids. What does all of this mean for you? Well, it has resulted in the reduction of the binding of insulin like growth factor binding proteins as well as increasing the potency of the peptide 10 fold.

  IGF - DES, often referred to as Des(1 - 3)IGF - 1, is a modified form of insulin - like growth factor 1 (IGF - 1). IGF - 1 is a protein naturally present in humans, playing a crucial role in childhood growth and maintaining anabolic effects in adults. The "Des" in its name indicates that it is a truncated peptide, with the first three amino acids at the N - terminus of the normal IGF - 1 molecule removed.

  
  

  
  

        IGF - DES binds to the IGF - 1 receptor and insulin receptors with different affinities compared to IGF - 1. Due to its smaller size, it has a significantly shorter half - life, which may lead to a more localized effect and reduced systemic availability. This peptide is mainly studied for its potential in promoting tissue growth and repair, especially in muscles. It is of great interest in research related to muscle regeneration, wound healing, and cell growth.

  
  

  
  

        In the medical research field, IGF - DES shows potential in multiple aspects. It is being studied for its neuroprotective and neuroregenerative properties, which could be beneficial for treating neurological conditions such as Parkinson's disease, multiple sclerosis, and spinal cord injuries. Research on autism spectrum disorders also includes IGF - DES, as it may affect neurological development and synaptic function, potentially providing new treatment approaches. Additionally, considering its role in cellular growth and neuroprotection, it might enhance cognitive functions and help mitigate age - related declines in memory and learning abilities.

  
  

        Overall, IGF - DES holds great potential in both research and possible future therapeutic applications, though further studies are still needed to fully explore and understand its functions and applications.

  Benefit  

  1.Promotes protein synthesis in the body.
  

  2.Shifting fat storage to energy production leads to significant fat loss.

  3.Has a positive effect on metabolism, increases lean body mass and reduces fat.

  4.Enhances the regenerative properties of nerve tissue in the body.

  5.Improves antioxidant benefits and strengthens ligaments.

  6.Promote the proliferation of muscle cells, make muscle tissue more plump.

  7.Improves cognitive function.

  Storage

  Conditions: Store in a cool and dry place.

    HaiKou Mingheng Technology Co., Ltd. was founded in 2019 has strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures. We effectively promote joint ventures and cooperation with major enterprises and manufacturers, and serve the society and the majority of users with the idea of industrialized development. We always adhere to the market demand-oriented, and constantly synthesize new chemical products and pharmaceutical intermediates with high technical content, mainly exported to the United States, India, South Africa, Nigeria and many other countries and regions, with rich experience in export, to ensure the safety of transportation, and to be able to let every customer receive the goods safely as early as possible.